ロード中...
FDA Approved Biologics: Can Etanercept and Ustekinumab be Considered a First-Line Systemic Therapy for Pediatric/Adolescents in Moderate to Severe Psoriasis? A Systematic Review
Psoriasis is a chronic immune-mediated skin disorder. Due to lack of clarity in its pathogenesis, a cure with existing treatment is a big challenge. Biologics, a revolutionary treatment, are potent immunomodulators that explicitly target the culprit cells of the immune system to achieve the maximum...
保存先:
| 出版年: | Cureus |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Cureus
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7494414/ https://ncbi.nlm.nih.gov/pubmed/32953323 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.9812 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|